@misc{MTMT:34406270,
	title = {Az elsővonalas immunterápia választásának aktualitásai},
	url = {https://m2.mtmt.hu/api/publication/34406270},
	author = {Horváth, Zsolt and Gálffy, Gabriella (kerekasztal-résztvevő) and Hitre, Erika and Torday, László (kerekasztal-résztvevő) and Géczi, Lajos},
	unique-id = {34406270},
	year = {2023},
	orcid-numbers = {Horváth, Zsolt/0000-0002-5376-7737; Géczi, Lajos/0000-0001-7432-2043}
}

@article{MTMT:34105055,
	title = {Opposite trends In incidence of breast cancer in young and old female cohorts in Hungary and the impact of the COVID-19 pandemic: a nationwide study between 2011–2020},
	url = {https://m2.mtmt.hu/api/publication/34105055},
	author = {Kiss, Zoltán and Kocsis, Judit and Nikolényi, Alíz and Horváth, Zsolt and Knollmajer, Kata and Benedek, Angela and Várnai, Máté and Polányi, Zoltán and Kovacs, Andrea Krisztina and Berta, Andrea and Köveskuti, István and Karamousouli, Eugenia and Szabó, Tamás G. and Rokszin, György Aurél and Bajcsayné Fábián, Ibolya and Bartókné Tamás, Renáta and Surján, Orsolya and Fürtős, Diána and Surján, György and Kenessey, István and Wéber, András and Barcza, Zsófia and Berki, Tamás and Vokó, Zoltán and Dózsa, Csaba and Dank, Magdolna and Boér, Katalin},
	doi = {10.3389/fonc.2023.1182170},
	journal-iso = {FRONT ONCOL},
	journal = {FRONTIERS IN ONCOLOGY},
	volume = {13},
	unique-id = {34105055},
	issn = {2234-943X},
	year = {2023},
	eissn = {2234-943X},
	orcid-numbers = {Horváth, Zsolt/0000-0002-5376-7737; Surján, György/0000-0001-5836-7647; Kenessey, István/0000-0002-6963-8489; Wéber, András/0000-0003-1605-8226; Berki, Tamás/0000-0001-6944-2331; Vokó, Zoltán/0000-0002-1004-1848; Dózsa, Csaba/0000-0003-4884-7537; Dank, Magdolna/0000-0002-4442-8733; Boér, Katalin/0000-0002-5101-7289}
}

@article{MTMT:34104957,
	title = {Abstract GS3-02: GS3-02 Camizestrant, a next generation oral SERD vs fulvestrant in post-menopausal women with advanced ER-positive HER2-negative breast cancer: Results of the randomized, multi-dose Phase 2 SERENA-2 trial},
	url = {https://m2.mtmt.hu/api/publication/34104957},
	author = {Oliveira, Mafalda and Pominchuck, Denys and Nowecki, Zbigniew and Hamilton, Erika and Kulyaba, Yaroslav and Andabekov, Timur and Hotko, Yevhen and Melkadze, Tamar and Nemsadze, Gia and Neven, Patrick and Semegen, Yuriy and Vladmirov, Vladmir and Zamagni, Claudio and Denys, Hannelore and Forget, Frederic and Horváth, Zsolt and Nesterova, Alfiya and Bennett, Maxine and Kirova, Bistra and Klinowska, Teresa and Lindemann, Justin and Lissa, Delphine and Mathewson, Alastair and Morrow, Christopher and Traugottova, Zuzana and Van Zyl, Ruaan and Arkania, Ekaterine},
	doi = {10.1158/1538-7445.SABCS22-GS3-02},
	journal-iso = {CANCER RES},
	journal = {CANCER RESEARCH},
	volume = {83},
	unique-id = {34104957},
	issn = {0008-5472},
	abstract = {Background Camizestrant (C), a next-generation oral selective estrogen receptor (ER) antagonist and degrader (ngSERD) has shown promising clinical activity in ER+ breast cancer (BC) in the Phase 1 SERENA-1 study1,2 with a dose-dependent safety profile. The Phase 2 randomized SERENA-2 study (NCT04214288) initially assessed three doses of C vs fulvestrant (F) in post-menopausal women with ER+ HER2˗ BC with disease recurrence or progression after ≤1 endocrine therapy (ET) in the advanced setting.},
	year = {2023},
	eissn = {1538-7445},
	pages = {GS3-02-GS3-02},
	orcid-numbers = {Horváth, Zsolt/0000-0002-5376-7737}
}

@article{MTMT:33929577,
	title = {A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer},
	url = {https://m2.mtmt.hu/api/publication/33929577},
	author = {Galffy, G. and Lugowska, I. and Poddubskaya, E.V. and Cho, B.C. and Ahn, M.-J. and Han, J.-Y. and Su, W.-C. and Hauke, R.J. and Dyar, S.H. and Lee, D.H. and Serwatowski, P. and Estelles, D.L. and Holden, V.R. and Kim, Y.J. and Vladimirov, V. and Horváth, Zsolt and Ghose, A. and Goldman, A. and di, Pietro A. and Wang, J. and Murphy, D.A. and Alhadab, A. and Laskov, M.},
	doi = {10.1016/j.esmoop.2023.101173},
	journal-iso = {ESMO OPEN},
	journal = {ESMO OPEN},
	volume = {8},
	unique-id = {33929577},
	issn = {2059-7029},
	year = {2023},
	eissn = {2059-7029},
	orcid-numbers = {Horváth, Zsolt/0000-0002-5376-7737}
}

@article{MTMT:33647465,
	title = {Corrigendum : Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer},
	url = {https://m2.mtmt.hu/api/publication/33647465},
	author = {Rubovszky, Gábor and Kocsis, Judit and Boér, Katalin and Chilingirova, Nataliya and Dank, Magdolna and Kahán, Zsuzsanna and Kaidarova, Dilyara and Kövér, Erika and Krakovská, Bibiana Vertáková and Máhr, Károly and Mriňáková, Bela and Pikó, Béla and Božović-Spasojević, Ivana and Horváth, Zsolt},
	doi = {10.3389/pore.2023.1610954},
	journal-iso = {PATHOL ONCOL RES},
	journal = {PATHOLOGY AND ONCOLOGY RESEARCH},
	volume = {29},
	unique-id = {33647465},
	issn = {1219-4956},
	keywords = {guideline; Early breast cancer; Metastatic breast cancer; adjuvant treatment; inflammatory breast cancer; locally advanced breast cancer; Neoadjuvant treatment},
	year = {2023},
	eissn = {1532-2807},
	orcid-numbers = {Rubovszky, Gábor/0000-0003-1723-5589; Boér, Katalin/0000-0002-5101-7289; Dank, Magdolna/0000-0002-4442-8733; Kahán, Zsuzsanna/0000-0002-5021-8775; Horváth, Zsolt/0000-0002-5376-7737}
}

@article{MTMT:33630503,
	title = {Személyre szabott orvoslás és egészségügy. hol tartunk, merre menjünk?},
	url = {https://m2.mtmt.hu/api/publication/33630503},
	author = {Gulácsi, László and Békássy, Sz. and Bittner, Nóra and Feith, Helga Judit and Ficzere, A. and Horváth, Lajos and Horváth, Zsolt and Tóth, I. and Zrubka, Zs. and Tóth, Erika and Kovács, L. Gábor},
	doi = {10.1556/650.2023.32711},
	journal-iso = {ORV HETIL},
	journal = {ORVOSI HETILAP},
	volume = {164},
	unique-id = {33630503},
	issn = {0030-6002},
	year = {2023},
	eissn = {1788-6120},
	pages = {202-209},
	orcid-numbers = {Feith, Helga Judit/0000-0001-8855-5059; Horváth, Zsolt/0000-0002-5376-7737; Tóth, Erika/0000-0003-2054-8447; Kovács, L. Gábor/0000-0001-5298-5401}
}

@{MTMT:32956307,
	title = {Onkológiai kezelések a palliatív ellátásban},
	url = {https://m2.mtmt.hu/api/publication/32956307},
	author = {Ruzsa, Ágnes and Horváth, Zsolt},
	booktitle = {Palliatív ellátás},
	unique-id = {32956307},
	year = {2022},
	pages = {341-351},
	orcid-numbers = {Horváth, Zsolt/0000-0002-5376-7737}
}

@article{MTMT:32946435,
	title = {Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer},
	url = {https://m2.mtmt.hu/api/publication/32946435},
	author = {Rubovszky, Gábor and Kocsis, Judit and Boér, Katalin and Chilingirova, Nataliya and Dank, Magdolna and Kahán, Zsuzsanna and Kaidarova, Dilyara and Kövér, Erika and Krakovská, Bibiana Vertáková and Máhr, Károly and Mriňáková, Bela and Pikó, Béla and Božović-Spasojević, Ivana and Horváth, Zsolt},
	doi = {10.3389/pore.2022.1610383},
	journal-iso = {PATHOL ONCOL RES},
	journal = {PATHOLOGY AND ONCOLOGY RESEARCH},
	volume = {28},
	unique-id = {32946435},
	issn = {1219-4956},
	year = {2022},
	eissn = {1532-2807},
	orcid-numbers = {Rubovszky, Gábor/0000-0003-1723-5589; Boér, Katalin/0000-0002-5101-7289; Dank, Magdolna/0000-0002-4442-8733; Kahán, Zsuzsanna/0000-0002-5021-8775; Horváth, Zsolt/0000-0002-5376-7737; Krenács, Tibor/0000-0001-9164-065X; Kulka, Janina/0000-0001-6498-5943; Polgár, Csaba/0000-0001-7245-0762; Koncz, Zsuzsa/0000-0003-1518-7253}
}

@article{MTMT:32946401,
	title = {Abstract CT533: Durvalumab (D) plus tremelimumab (T) in platinum-refractory/resistant extensive-stage small cell lung cancer (ES-SCLC): Efficacy, safety and ctDNA dynamics from Arm A of the phase 2 BALTIC study},
	url = {https://m2.mtmt.hu/api/publication/32946401},
	author = {Reinmuth, Niels and Juan-Vidal, Oscar and Horváth, Zsolt and Kowalski, Dariusz and Kryzhanivska, Anna and Csánky, Eszter and Gálffy, Gabriella and Bryl, Maciej and Vicente, David and Vynnychenko, Ihor and Pápai-Székely, Zsolt and Armstrong, Jon and Dalvi, Tapashi and Shrestha, Yashaswi and Xie, Mingchao and Jiang, Haiyi and Bondarenko, Igor},
	doi = {10.1158/1538-7445.AM2022-CT533},
	journal-iso = {CANCER RES},
	journal = {CANCER RESEARCH},
	volume = {82},
	unique-id = {32946401},
	issn = {0008-5472},
	year = {2022},
	eissn = {1538-7445},
	pages = {CT533-CT533},
	orcid-numbers = {Horváth, Zsolt/0000-0002-5376-7737}
}

@article{MTMT:32704404,
	title = {A hepatocellularis carcinoma komplex kezelése. Konszenzuskonferencia, Budapest, 2021. április 24.},
	url = {https://m2.mtmt.hu/api/publication/32704404},
	doi = {10.1556/650.2021.32431},
	journal-iso = {ORV HETIL},
	journal = {ORVOSI HETILAP},
	volume = {162},
	unique-id = {32704404},
	issn = {0030-6002},
	keywords = {RANDOMIZED CONTROLLED-TRIAL; LONG-TERM OUTCOMES; stereotactic body radiotherapy; Transcatheter arterial chemoembolization; Future liver remnant; LYMPH-NODE METASTASES; PORTAL-VEIN EMBOLIZATION; PERCUTANEOUS RADIOFREQUENCY ABLATION; SEQUENTIAL TRANSARTERIAL CHEMOEMBOLIZATION},
	year = {2022},
	eissn = {1788-6120},
	pages = {2-31},
	orcid-numbers = {Kokas, Bálint András/0000-0001-6747-4604; Bodoky, György/0000-0002-5659-2020; Dank, Magdolna/0000-0002-4442-8733; Doros, Attila/0000-0002-6496-9895; Györke, Tamás/0000-0002-8772-9931; Hagymási, Krisztina/0000-0002-5859-1320; Hőhn, József/0000-0001-6706-4162; Petri, András/0000-0002-4526-4427; Piros, László/0000-0003-4841-220X; Székely, Eszter/0000-0001-5039-8721; Torday, László/0000-0002-2911-5499; Dósa, Edit/0000-0003-2984-2642; Harsányi, László/0000-0003-2657-0039; Horváth, Zsolt/0000-0002-5376-7737; Lázár, György ifj/0000-0001-7155-2978; Lengyel, Gabriella/0000-0001-7560-9492; Maurovich-Horvat, Pál/0000-0003-0885-736X; Palkó, András/0000-0002-5370-6934; Schaff, Zsuzsa/0000-0002-6429-8059; Szalay, Ferenc/0000-0003-2771-7362}
}